drugset / Trial / NCT02889666
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Phase 1
Recruiting
500 enrolled
Shanghai Jiao Tong University School of Medicine
Jiangxi Provincial Cancer Hospital · collabJilin University · collabShanghai 10th People's Hospital · collabShanghai Tongji Hospital, Tongji University School of Medicine · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the commonly administered chemotherapeutic agents including cisplatin, carboplatin, oxaliplatin, docetaxel and gemcitabine for solid tumors in clinical oncology, either a single format or given as combinations followed by surgery are effective in the treatment of relapsed and refractory non-small cell lung cancer patients.
Timeline
- Start
- 2008-01
- Primary completion
- 2026-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 400 mg | Intravenous |
| Subject | Cisplatin | Other / unclassified | 60 mg | Intravenous |
| Subject | Docetaxel | Small molecule | 120 mg | Intravenous |
| Subject | Gemcitabine | Small molecule | 200 mg | Intravenous |
| Subject | Oxaliplatin | Small molecule | 200 mg | Intravenous |